Literature DB >> 11935302

The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.

J Huober1, A Meyer, U Wagner, D Wallwiener.   

Abstract

Radical debulking surgery allows for optimal cytoreduction in less than 50% of patients with advanced ovarian cancer. In spite of highly efficient chemotherapeutic regimens, the prognosis of patients with residual tumor masses larger than 1 cm in diameter following staging laparotomy is very poor. This observation led to the initiation of numerous trials evaluating the feasibility and efficiency of the use of primary chemotherapy followed by interval laparotomy in women with advanced ovarian cancer. The available data is presented and discussed in this review.

Entities:  

Mesh：

Year:  2002        PMID： 11935302     DOI： 10.1007/s00432-001-0312-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  9 in total

Review 1.  Selecting the best strategy of treatment in newly diagnosed advanced-stage ovarian cancer patients.

Authors:  Lucas Minig; Cristina Zorrero; Pablo Padilla Iserte; Andres Poveda
Journal:  World J Methodol       Date:  2015-12-26

2.  Comparison of Platinum-based Neoadjuvant Chemotherapy and Primary Debulking Surgery in Patients with Advanced Ovarian Cancer.

Authors:  Manizheh Sayyah-Melli; Gita Kashi Zonoozi; Shahryar Hashemzadeh; Ali Esfahani; Elaheh Ouladehsahebmadarek; Mehry Jafary Shobeiry; Parvin Mostafa Garabaghi; Azhough Ramin
Journal:  J Obstet Gynaecol India       Date:  2013-08-14

3.  Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer.

Authors:  Dae Chul Jung; Sokbom Kang; Min Ju Kim; Sang Yoon Park; Hyun Beom Kim
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

Review 4.  Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI.

Authors:  Rosemarie Forstner
Journal:  Eur Radiol       Date:  2007-08-14       Impact factor: 5.315

Review 5.  The role of interval debulking surgery in ovarian cancer.

Authors:  Maria E L van der Burg; Ignace Vergote
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

6.  Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.

Authors:  Oleg Mironov; Evis Sala; Svetlana Mironov; Harpreet Pannu; Dennis S Chi; Hedvig Hricak
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

7.  Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients.

Authors:  Arturas Inciura; Andrius Simavicius; Elona Juozaityte; Juozas Kurtinaitis; Ruta Nadisauskiene; Eimantas Svedas; Skirmantas Kajenas
Journal:  BMC Cancer       Date:  2006-06-08       Impact factor: 4.430

8.  Therapeutic effect of two transition metal coordination polymers on ovarian cancer by regulating the expression of estrogen receptor.

Authors:  Jin Zhao; Lan Du
Journal:  Des Monomers Polym       Date:  2022-02-09       Impact factor: 2.650

9.  Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy.

Authors:  Jean-Luc Brun; Roman Rouzier; Frédéric Selle; Sidney Houry; Serge Uzan; Emile Daraï
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.